| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6054529 | Oral Oncology | 2016 | 8 Pages |
Abstract
HPV-related OPSCCs had similar survival benefits across these three regions. Prognostic utility of HPV among non-OP HNSCC is limited so tumor HPV/p16 testing should not be routinely done among non-OP HNSCC.
Related Topics
Health Sciences
Medicine and Dentistry
Dentistry, Oral Surgery and Medicine
Authors
Gypsyamber D'Souza, Devasena Anantharaman, Tarik Gheit, Behnoush Abedi-Ardekani, Daniel C. Beachler, David I. Conway, Andrew F. Olshan, Victor Wunsch-Filho, Tatiana N. Toporcov, Wolfgang Ahrens, Kathy Wisniewski, Franco Merletti, Stefania Boccia,